{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-260809","form_type":"8-K","ticker":"HCA","cik":"0000860730","company_name":"HCA Healthcare, Inc.","filed_at":"2025-10-31T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.385145+00:00","generated_at":"2026-05-17T01:11:25.961796+00:00","sec_items":["1.01","2.03","8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"HCA issues $3.25B senior notes: 4.30% 2030, 4.60% 2032, 4.90% 2035, 5.70% 2055","bullets":["$500M 4.30% notes due 2030, $1B 4.60% due 2032, $1B 4.90% due 2035, $750M 5.70% due 2055.","Interest payable semi-annually May 15 and Nov 15, beginning May 15, 2026.","Notes are senior unsecured obligations of HCA Inc., fully guaranteed by HCA Healthcare.","Rank equally with existing senior debt; effectively subordinated to secured debt and structurally subordinated to subsidiary liabilities.","Underwriting led by J.P. Morgan, Citigroup, Mizuho, and Wells Fargo; redemption and change-of-control put at 101%."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-260809","json":"https://secwatch.observer/filing/0001193125-25-260809.json","markdown":"https://secwatch.observer/filing/0001193125-25-260809.md","text":"https://secwatch.observer/filing/0001193125-25-260809.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/860730/000119312525260809/0001193125-25-260809-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/860730/000119312525260809/d38508d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:11:25.961796+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"aca2f5779e254a0e5436cb31ef3c8df668fe90a8","claim":"HCA Healthcare, Inc. incurred senior notes of $3,250,000,000 aggregate principal amount with Public offering at 4.300%, 4.600%, 4.900%, 5.700% maturing 2030 Notes mature November 15, 2030; 2032 Notes mature November 15, 2032; 2035 Notes mature November 15, 2035; 2055 Notes mature November 15, 2055.","evidence_excerpt":"any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 1.01 Entry into a Material Definitive Agreement. Issuance of $3,250,000,000 aggregate principal amount of senior notes Overview On October 31, 2025, HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of HCA Healthcare, Inc. (the “Parent","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/860730/000119312525260809/0001193125-25-260809-index.htm","confidence":0.99,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"senior notes"},{"label":"Principal","value":"$3,250,000,000 aggregate principal amount"},{"label":"Counterparty","value":"Public offering"},{"label":"Rate","value":"4.300%, 4.600%, 4.900%, 5.700%"},{"label":"Maturity","value":"2030 Notes mature November 15, 2030; 2032 Notes mature November 15, 2032; 2035 Notes mature November 15, 2035; 2055 Notes mature November 15, 2055"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}